Evidence Synthesis
BPL Pharma's standard shift narrative on September 5, 2026, indicates a mixed performance across various key metrics.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 5 Sept 2026, 03:33
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
BPL Pharma's standard shift narrative on September 5, 2026, indicates a mixed performance across various key metrics.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 47.75 % | -0.16 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -0.16 % | -4.77 | ▲ |
| REVENUE_GROWTH_YOY | -19.2 % | — | - |
| PRICE_CHANGE_PERCENT | -0.456 % | — | - |
| DAILY_VOLUME | 247 shares | 1,769 | ▼ |
| CLOSE_PRICE | 1,527.95 INR | 1,534.95 | ▼ |